Answers are grounded in this paper and cite their sources.
Background: Pavlik harnesses are largely successful in treating infantile developmental dysplasia of the hip (DDH). However, 5% to 30% of patients “successfully” treated still demonstrate persistent dysplasia on follow-up pelvic radiographs. The purpose of this study was to determine whether 3-dimensional ultrasound (3D US) metrics could more reliably predict residual dysplasia following seemingly “successful” Pavlik harness treatment. Methods: We identified 138 hips in 83 patients with DDH who were treated with a Pavlik and had complete 3D US data sets before harness initiation. At the time the hip was deemed “normal,” weaning was commenced. Forward binary logistic regression of demographics, 2D alpha, beta, and gamma angles, femoral head coverage (FHC), and 4 validated 3D metrics [anterior, mid, and posterior alpha angles, and acetabular contact angle (ACA)], from both initial and weaning scans, was conducted. The ACA is the angle between the resultant vector of the ilium and the acetabular surface, which may be more representative of global dysplasia than the conventional alpha angle. Results: In our cohort, 23 of 138 infants (16.6%) demonstrated radiographic dysplasia at 6 months after “successful” Pavlik treatment. In multivariate regression analysis, factors that significantly increased the risk of dysplasia were age at Pavlik wean less than 81 days ( P =0.002, OR=4.34) and acetabular contact angle (ACA) at wean less than 50 degrees ( P =0.0003, OR =2.94). Adding 3D measurements to a multivariate logistic regression model improved the model’s sensitivity for predicting residual dysplasia at 6 months from 4% in a model with 2D measurements to 19% with addition of 3D variables. Conclusions: Conventional 2D US definitions of a “normal” hip (i.e., alpha angle >60 degrees, %FHC >50%) may not be sufficient given a 16.6% incidence of radiographic dysplasia at 6 months. Three-dimensional US variables, such as ACA, significantly improve the accuracy of models for predicting residual dysplasia and may someday help better define what constitutes a truly normal hip following treatment. Level of Evidence: Level III—retrospective comparative study.
No takes yet. Share an insight, caveat, or question.
Blanchard et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: